Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
2023 Standout
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
Works of E. Senn being referenced
Immediate Versus Deferred Hormonal Treatment for Patients With Prostate Cancer Who Are Not Suitable for Curative Local Treatment: Results of the Randomized Trial SAKK 08/88
2004
Adjuvant Cisplatin Chemotherapy Following Cystectomy for Bladder Cancer: Results of a Prospective Randomized Trial
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E. Senn | 340 | 168 | 10 | 181 | 11 | 547 | |
| Shigeki Yamauchi | 491 | 93 | 13 | 19 | 19 | 636 | |
| Felix Ma | 127 | 38 | 8 | 56 | 10 | 469 | |
| Christophe Becker | 551 | 39 | 6 | 35 | 14 | 576 | |
| C.I. Orton | 289 | 42 | 11 | 30 | 11 | 493 | |
| DM Rosenbaum | 283 | 156 | 189 | 59 | 15 | 561 | |
| David A. Hochberg | 234 | 336 | 22 | 409 | 15 | 616 | |
| Thomas K. Chacko | 358 | 102 | 2 | 37 | 9 | 583 | |
| Maryellen O’Sullivan | 183 | 413 | 17 | 49 | 9 | 602 | |
| Adrian C. Day | 400 | 190 | 82 | 10 | 515 | ||
| Kay L. Cooper | 368 | 185 | 23 | 13 | 591 |
All Works
Loading papers...